Office of the Director, Office of Strategy and Innovation, Office of Minority Health and Health Disparities, 8700-8701 [E8-2789]
Download as PDF
<![CDATA[
8700
Federal Register / Vol. 73, No. 31 / Thursday, February 14, 2008 / Notices
Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8–2796 Filed 2–13–08; 8:45 am]
Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Service
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8–2795 Filed 2–13–08; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee (BCCEDCAC)
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Monitoring and
Evaluation of Malaria Activities in the
Greater Mekong Sub-Region, Request
for Applications (RFA) CK08–003
rwilkins on PROD1PC63 with NOTICES
In accordance with section 10(a)(2)of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5p.m., March
4, 2008. 8:30 a.m.–1p.m., March 5, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Tom
Harkin Global Community Center, Building
19, Atlanta, Georgia 30333, Telephone: (404)
639–1717.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Secretary, Department of Health
and Human Services, and the Director, CDC,
regarding the early detection and control of
breast and cervical cancer. The committee
makes recommendations regarding national
program goals and objectives;
implementation strategies; and program
priorities including surveillance,
epidemiologic investigations, education and
training, information dissemination,
professional interactions and collaborations,
and policy.
Matters To Be Discussed: The agenda will
include a review and discussion of the
National Breast and Cervical Cancer Early
Detection Program components; and related
policies and emerging issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Debra Younginer, Executive Secretary,
BCCEDCAC, Division of Cancer Prevention
and Control, National Center for Chronic
Disease Prevention and Health Promotion,
CDC, 4770 Buford Highway, Mailstop K–57,
Chamblee, Georgia 30316, Telephone: (770)
488–1074.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005
16:49 Feb 13, 2008
Jkt 214001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–2 p.m.,
March 13, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Monitoring and
Evaluation of Malaria Activities in the
Greater Mekong Sub-Region, RFA
CK08–003.’’
Contact Person For More Information:
Christine Morrison, PhD, Scientific
Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone: (404)
639–3098.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 7, 2008.
Elaine L. Baker
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–2793 Filed 2–13–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Natural History
and Prevention of Viral Hepatitis
Among Alaska Natives, Request for
Applications (RFA) PS08–004
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–4 p.m., March 24,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Natural History and
Prevention of Viral Hepatitis Among Alaska
Natives, RFA PS08–004.’’
Contact Person for More Information:
Shree Marshall Williams, PhD, M.Sc.,
Scientific Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72, Atlanta, GA
30333, Telephone: (404) 639–4896.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 8, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–2799 Filed 2–13–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Office of the Director, Office of
Strategy and Innovation, Office of
Minority Health and Health Disparities
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of September 23, 2004,
Consultation and Coordination with
Indian Tribal Governments, the CDC
announces the following meeting:
Name: Tribal Consultation Advisory
Committee (TCAC) Meeting, An
E:\FR\FM\14FEN1.SGM
14FEN1
rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 73, No. 31 / Thursday, February 14, 2008 / Notices
Overview and Orientation to CDC, and
the Biannual Tribal Consultation
Session.
Times and Dates:
8 a.m.–5:30 p.m., February 26, 2008;
TCAC Meeting.
8 a.m.–5:30 p.m., February 27, 2008;
An Overview and Orientation to CDC.
8 a.m.–5:30 p.m., February 28, 2008;
Biannual Tribal Consultation Session.
Place: Centers for Disease Control
(CDC), 1600 Clifton Road NE, Atlanta,
GA 30333, Telephone: 404–498–2343.
Roybal Campus—Building 19, Room
206 Auditorium A.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: CDC established the Tribal
Consultation Policy in October of 2005
with the primary purpose of providing
guidance across the agency to work
effectively with American Indian/
Alaska Native (AI/AN) communities and
organizations to enhance AI/AN access
to CDC programs. In October of 2005, an
Agency Advisory Committee (CDC/
ATSDR Tribal Consultation Advisory
Committee—TCAC) was established to
provide a complementary venue
wherein tribal representatives and CDC
staff will exchange information about
public health issues in Indian Country,
identifying urgent public health issues
in Indian country, and discuss
collaborative approaches to these issues.
Within the CDC Consultation Policy, it
is stated that CDC will conduct
Government-to-government consultation
with elected tribal officials or their
designated representatives and also
confer with tribal and Alaska Native
organizations and AI/AN urban and
rural communities before taking actions
and/or making decisions that affect
them. Consultation is an enhanced form
of communication that emphasizes
trust, respect, and shared responsibility.
It is an open and free exchange of
information and opinion among parties
that leads to mutual understanding and
comprehension. CDC believes that
consultation is integral to a deliberative
process that results in effective
collaboration and informed decision
making with the ultimate goal of
reaching consensus on issues. Although
formal responsibility for the agency’s
overall Government-to-government
consultation activities rests within the
Office of the Director, Coordinating
Centers and Coordinating Offices, and
center leadership shall actively
participate in TCAC meetings and HHSsponsored regional and national tribal
consultation sessions as frequently as
possible.
VerDate Aug<31>2005
16:49 Feb 13, 2008
Jkt 214001
Matters To Be Discussed: The TCAC
will convene their quarterly committee
meeting with discussions and
presentations from various CDC senior
leadership on activities and areas
identified by tribal leaders as priority
public health issues. The Tribal Leaders
Orientation Agenda has been
established in response to tribal leaders’
request to learn more about the CDC and
its potential resources available. The
Biannual Tribal Consultation Session
will engage CDC Senior leadership from
the Office of the Director and various
CDC Offices and National Centers
including the Financial Management
Office, National Center for
Environmental Health and the Agency
for Toxic Substances, Coordinating
Office for Terrorism and Preparedness
and Emergency Response, National
Center for Health Marketing, the Office
of Chief of Public Health Practice, and
the Office of Enterprise
Communications. Opportunities will be
provided during the Consultation
Session for tribal testimony. Tribal
Leaders are encouraged to submit
written testimony by COB on February
8, 2008 to the contact person below.
Depending on the time available it may
be necessary to limit the time of each
presenter.
Please reference this web link https://
www.cdc.gov/omhd/TCAC/AAC.html to
review information about the TCAC and
CDC’s tribal Consultation Policy.
For Further Information Contact:
CAPT Pelagie (Mike) Snesrud, Senior
Tribal Liaison for Policy and Evaluation,
Office of Minority Health and Health
Disparities, 1600 Clifton Road NE., MS
E–67, Atlanta, Georgia 30333, telephone
(404) 498–2343, fax (404) 498–2355, email: pws8@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the CDC
and Agency for Toxic Substances and
Disease Registry.
Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–2789 Filed 2–13–08; 8:45 am]
BILLING CODE 4160–18–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
8701
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; comment
request; The REDS-II Donor Iron Status
Evaluation (RISE) Study
SUMMARY: In compliance with the
requirement of Section 3506(c) (2) (A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Heart, Lung, and Blood
Institute (NHLBI), the National
Institutes of Health (NIH), will publish
periodic summaries of proposed
projects to the Office of Management
and Budget (OMB) for review and
approval.
PROPOSED COLLECTION: Title: The REDSII Donor Iron Status Evaluation (RISE)
Study. Type of Information Collection
Request: Revisions due to program
adjustments. Need and Use of
Information Collection: Although the
overall health significance of iron
depletion in blood donors is uncertain,
iron depletion leading to iron deficient
erythropoiesis and lowered hemoglobin
levels results in donor deferral and,
occasionally, in mild iron deficiency
anemia. Hemoglobin deferrals represent
more than half of all donor deferral,
deferring 16% of women.
Several cross sectional studies of
blood donors, using older measures of
iron status in blood donors have
indicated that female sex, frequent
donation and not taking iron
supplements are predictors of iron
depletion. However, none of these
studies have included racial/ethnic,
anthropomorphic, or behavioral factors
and none have evaluated the impact of
newly discovered iron protein
polymorphisms. The RISE Study is a
longitudinal study of iron status in two
cohorts of blood donors: A first time/
reactivated donor cohort in which
baseline iron and hemoglobin status can
be assessed without the influence of
previous donations, and a frequent
donor cohort, where the cumulative
effect of additional frequent blood
donations can be assessed. Each cohort’s
donors will donate blood and provide
evaluation samples during the study
period.
The primary goal of the study is to
evaluate the effects of blood donation
intensity on iron and hemoglobin status
and assess how these are modified as a
function of baseline iron/hemoglobin
measures, demographic factors, and
reproductive and behavioral factors.
Hemoglobin levels, a panel of iron
protein, red cell and reticulocyte indices
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 73, Number 31 (Thursday, February 14, 2008)]
[Notices]
[Pages 8700-8701]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2789]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Office of the Director, Office of Strategy and Innovation, Office
of Minority Health and Health Disparities
In accordance with Presidential Executive Order No. 13175, November
6, 2000, and the Presidential Memorandum of September 23, 2004,
Consultation and Coordination with Indian Tribal Governments, the CDC
announces the following meeting:
Name: Tribal Consultation Advisory Committee (TCAC) Meeting, An
[[Page 8701]]
Overview and Orientation to CDC, and the Biannual Tribal Consultation
Session.
Times and Dates:
8 a.m.-5:30 p.m., February 26, 2008; TCAC Meeting.
8 a.m.-5:30 p.m., February 27, 2008; An Overview and Orientation to
CDC.
8 a.m.-5:30 p.m., February 28, 2008; Biannual Tribal Consultation
Session.
Place: Centers for Disease Control (CDC), 1600 Clifton Road NE,
Atlanta, GA 30333, Telephone: 404-498-2343. Roybal Campus--Building 19,
Room 206 Auditorium A.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: CDC established the Tribal Consultation Policy in October
of 2005 with the primary purpose of providing guidance across the
agency to work effectively with American Indian/Alaska Native (AI/AN)
communities and organizations to enhance AI/AN access to CDC programs.
In October of 2005, an Agency Advisory Committee (CDC/ATSDR Tribal
Consultation Advisory Committee--TCAC) was established to provide a
complementary venue wherein tribal representatives and CDC staff will
exchange information about public health issues in Indian Country,
identifying urgent public health issues in Indian country, and discuss
collaborative approaches to these issues. Within the CDC Consultation
Policy, it is stated that CDC will conduct Government-to-government
consultation with elected tribal officials or their designated
representatives and also confer with tribal and Alaska Native
organizations and AI/AN urban and rural communities before taking
actions and/or making decisions that affect them. Consultation is an
enhanced form of communication that emphasizes trust, respect, and
shared responsibility. It is an open and free exchange of information
and opinion among parties that leads to mutual understanding and
comprehension. CDC believes that consultation is integral to a
deliberative process that results in effective collaboration and
informed decision making with the ultimate goal of reaching consensus
on issues. Although formal responsibility for the agency's overall
Government-to-government consultation activities rests within the
Office of the Director, Coordinating Centers and Coordinating Offices,
and center leadership shall actively participate in TCAC meetings and
HHS-sponsored regional and national tribal consultation sessions as
frequently as possible.
Matters To Be Discussed: The TCAC will convene their quarterly
committee meeting with discussions and presentations from various CDC
senior leadership on activities and areas identified by tribal leaders
as priority public health issues. The Tribal Leaders Orientation Agenda
has been established in response to tribal leaders' request to learn
more about the CDC and its potential resources available. The Biannual
Tribal Consultation Session will engage CDC Senior leadership from the
Office of the Director and various CDC Offices and National Centers
including the Financial Management Office, National Center for
Environmental Health and the Agency for Toxic Substances, Coordinating
Office for Terrorism and Preparedness and Emergency Response, National
Center for Health Marketing, the Office of Chief of Public Health
Practice, and the Office of Enterprise Communications. Opportunities
will be provided during the Consultation Session for tribal testimony.
Tribal Leaders are encouraged to submit written testimony by COB on
February 8, 2008 to the contact person below. Depending on the time
available it may be necessary to limit the time of each presenter.
Please reference this web link https://www.cdc.gov/omhd/TCAC/
AAC.html to review information about the TCAC and CDC's tribal
Consultation Policy.
For Further Information Contact: CAPT Pelagie (Mike) Snesrud,
Senior Tribal Liaison for Policy and Evaluation, Office of Minority
Health and Health Disparities, 1600 Clifton Road NE., MS E-67, Atlanta,
Georgia 30333, telephone (404) 498-2343, fax (404) 498-2355, e-mail:
pws8@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the CDC and Agency for Toxic Substances and Disease Registry.
Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-2789 Filed 2-13-08; 8:45 am]
BILLING CODE 4160-18-P
